How Much Do Vegan Diets Improve the Health of Dogs?
WINCHESTER, UK / ACCESSWIRE / September 5, 2024 / Pet food consumes at least 9% of all livestock globally, rising to 20% in nations such as the US with high pet ownership. The environmental benefits of vegan pet diets were recently found to be game-changingly large. Most of these relate to dog food. But, can dogs be healthy without consuming meat?
Dogs are biologically omnivores, and many companies now produce vegan dog food using plant, mineral and synthetic ingredients to supply all necessary nutrients. By 2024, 10 scientific studies had demonstrated good health outcomes in dogs fed vegan or vegetarian diets, and the British Veterinary Association had endorsed nutritionally-sound vegan dog diets. Yet no studies had calculated the size of the health benefits that might occur for average dogs, after controlling for age, sex, neutering status, breed size and exercise level - all factors that can affect dog health.
In 2024 veterinary Professor Andrew Knight and two colleagues published the first study to control for all of these factors. After analysing health outcomes for 2,536 dogs, including 336 fed a vegan diet for at least one year, they found decreases in the occurrences of seven general indicators of illness. Dogs fed vegan diets were less likely to need medication, medical diets or unusually high numbers of veterinary visits, were more likely to be assessed as healthy by dog owners and their veterinarians, had lower rates of illness, and fewer cases of health disorders when they were unwell. Reductions ranged from 14% - 51% for average dogs, compared to dogs fed conventional meat-based diets. All of these differences were statistically significant, meaning they almost certainly reflected true differences rather than random variation.
Additionally, the odds of suffering from six specific health disorders fell by 50%-61% compared to dogs fed conventional meat. These included some of the most common health disorders in dogs: problems with body weight, ears, and the musculoskeletal and gastrointestinal system - which can cause conditions such as lameness and diarrhoea.
Among the 22 most common health disorders found in a 2022 study of the same dogs, 11 were most common in dogs fed conventional meat, eight in dogs fed raw meat, and three most common in dogs few vegan diets. 49% of dogs fed conventional meat were unwell, compared to 43% fed raw meat, and 36% fed vegan diets.
Stated Prof. Knight, "Dogs fed vegan diets clearly had the best health outcomes in this very large-scale study, and these results are consistent with prior studies in this field. Nutritionally-sound vegan diets offer extremely large environmental benefits, so this is very good news for dog owners who want to protect the environment whilst also maximising their dogs' health. However, care should always be taken to ensure diets are nutritionally-sound, by checking package labelling and purchasing from reputable pet food companies."
Contact Information
Andrew Knight
Veterinary Professor of Animal Welfare
andrew.knight@murdoch.edu.au
SOURCE: Prof. Andrew Knight
View the original press release on newswire.com.
Representing Animals Foundation

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom